Drug Profile
SAR 127963
Alternative Names: SAR127963Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Sanofi
- Class
- Mechanism of Action Nerve growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Brain injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Brain injuries in France
- 31 Mar 2012 Phase-I clinical trials in Brain injuries in France (unspecified route)